source of plasminogen activator (PA) and thus of blood vessel-associated fibrinolytic activity. Cultured bovine aortic endothelial cells were employed to determine if components of the coagulation system interact with the endothelium to modify expression of this activity. The addition of thrombin to these cultures led to a rapid decline in intracellular PA activity, with as little as 3 ng/ml, or 0.1 nM thrombin causing a 50% decrease within 30 min. Thrombin inactivated with diisopropylfluorophosphate or hirudin did not elicit the response. Although control cultures secreted high levels of PA, no PA activity could be detected in the media surrounding the thrombin-treated cells. This loss of activity did not appear to result from direct inactivation of PA by thrombin. These observations indicate that the fibrinolytic potential of cultured endothelial cells is rapidly suppressed by trace amounts of thrombin. The generation of thrombin at sites of vascular injury may have a similar effect on the endothelium.
INTRODUCTION
The production of plasminogen activator (PA)' by the endothelium (1) emphasizes the potential role of endothelial cell(s) (EC[s] ) in maintaining vessel patency and initiating thrombolysis. At the same time, however, the presence of PA in the area of vascular injury would appear to compromise the hemostatic function of the damaged endothelium by converting circulatinig plasminogen into plasmin (2) and thus initiating premature lysis of the fibrin-platelet thrombbus. We 
have been
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METHODS
Cell culture. ECs were isolated from the aortas of freshly slaughtered adult cows by gentle collagenase treatment (5) . Cells were cultured in 35-mm tissue culture dishes in 1 ml of modified Eagle's medium (MEM) supplemented with 10% fetal calf serum (Reheis Co., Inc., Phoenix, Ariz.) as described (3, 4) . Cultures were seeded at 200,000 cells/dish, grew with a generation time of 24-28 h, and reached a density of 0.8-1.2 x 106 cells/dish at confluency. These monolayers were wellcontact inhibited and could be maintained for 2-4 wk without refeeding and without change in culture morphology. The cells used in these experiments had been subcultured 15-20 times and were employed 1-7 d after visual confluency was reached. Similar results were obtained in preliminary experiments with cells passaged only three times.
Preparation ofcell extracts and conditioned media. Monolayers were washed three times with cold phosphate-buffered saline (PBS) and either extracted with 0.5% Triton X-100 (Rohm and Haas Co., Philadelphia, Pa.) (3), or incubated in serum-free MEM at 37°C for various times to prepare conditioned media (CM) containing PA. The extracts and CM were then assayed for fibrinolytic activity. Hirudin (Sigma Chemical Co., St. Louis, Mo.) was added to CM collected from thrombin-treated cultures. It did not affect fibrinolysis assays.
Fibriniolytic activity. '251-Fibrin-coated multiwell culture dishes were prepared as described (3) and employed to measure the fibrinolytic activity of cell extracts and CM. Each well contained 20 jig fibrinogen and 100,000 cpm. The rate of fibrinolysis was determined by monitoring the release ofradioactivity from the surface of the dish into the assay buffer at various times. The standard cell-free assay contained in 1 ml: 4 ,ag human plasminogen, 0.1% gelatin, 0.5% Triton X-100, and 0.1 M Tris-HCl, pH 8.1, and was supplemented with cell extract or CM as a source of PA. Background fibrinolysis observed in the absence of a PA source was subtracted from each sample. Fibrinolytic activity was not observed in the absence of plasminogen. The results are the average of duplicate determinations and represent <15% variation.
Thrombin treatment. Monolayers were incubated at 37'C for various times in serum-free MEM containing human a-thrombin (kindly provided by Dr. J. W. Fenton, Jr.: 2,545 NIH U/mg), and cell extracts and CM were prepared. Inactive thrombin was prepared by incubating thrombin (100 U/ml in PBS containing 0.1% gelatin) with 500 U/ml of hirudin or 10 mM diisopropylfluorophosphate (DFP) for 2 h at 37°C. The DFP-treated sample was dialyzed overnight against PBS at 4'C.
Miscellaneous. Human plasminogen was prepared by lysine affinity chromatography (6), protein was determined by the method of Bradford (7), and radioactivity was measured in a Packard gamma spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). All chemicals and reagents were of analytical grade.
RESULTS
Effect of thrombin on intracellular PA activity. Thrombin binds to ECs with high affinity (8) , causing alterations in prostacyclin production (9) . EC monolayers were incubated with increasing concentrations of thrombin to determine whether production of other endothelial products is also influenced by this enzyme. No change in the morphology of these cells was observed, even after 24 h in the presence of 10 U/ml of thrombin. However, thrombin dramatically reduced intracellular PA activity (Fig. 1) , with as little as 2.5 mU/ml causing a significant decrease within 30 min. The maximum decrease was consistently observed at 2-4 U/ml, and resulted in a loss of 75-95% of the activity. The half-maximal response was elicited with 7-10 mU/ml, or -0.1 nM thrombin. Thrombin pre- treated with hirudin or DFP (Table I) did not cause the decrease, even when tested at 10 U/ml. Effect of thrombin on secretion of PA. Thrombin stimulates secretion by platelets (10) and fibroblasts (11) . CM was prepared from thrombin-treated and untreated monolayers to test the possibility that the decrease in intracellular PA was also due to secretion. Washed monolayers were exposed to thrombin (1 U/ml), and at various times thereafter an aliquot of the media was removed and tested for PA activity (Fig. 2) . PA activity was high in CM removed from untreated cultures. It was detected within the first 30 min and continued to accumulate for the next 3.5 h. In contrast, Thrombin (Units/ml) FIGURE 1 Effect of thrombin on intracellular PA activity. EC monolayers were incubated for 30 min in the presence of increasing concentrations of thrombin, extracted, and tested for PA activity. The PA activity in 5 ,ug of each extract was normalized to that in the untreated control cultures which hydrolyzed 20% of the fibrin in the 2-h assay. Time IHoursl FIGURE 2 Accumulation of PA activity in media from thrombin-treated and untreated ECs. Thrombin (1 U/ml) was added to EC monolayers. At various times an aliquot (25 Al) of the media was removed and tested for PA activity in assay buffer containing hirudin (1 U/ml). Untreated (0) and thrombin treated (0). only minimal PA activity was detected in the thrombintreated cultures. CM prepared for 4 h from treated cultures had less PA activity than CM recovered from untreated cultures after only 1 h.
Effect of thrombin on PA itself. The low PA activity of CM from thrombin-treated cultures did not result from direct inactivation of PA by the thrombin. Thus, when thrombin was added to the media covering cultured cells, intracellular and secreted PA decreased by 80 and 92%, respectively, within 30 min (Table II) . However, when it was added directly to CM previously removed from cells, the rate of loss was considerably slower. Under these conditions, the activity declined by only 16% in 30 min. Approximately 60% of the control activity still remained after 90 min of treatment. Thrombin incubated with CM for 90 min still retained its procoagulant activity as measured in a fibrinogen clotting assay.
DISCUSSION
Thrombin is a highly specific serine protease whose primary biological activity appears to be related to its effect on platelets (10) and its critical role in blood coagulation (12) . It is also apparent, however, that thrombin may influence the behavior of a variety of cells. Thus, it is mitogenic for some cells (13, 14) , it stimulates the production and release of fibronectin from the surface of fibroblasts (11), and it enhances the release of prostacyclin from ECs (9). The results presented in this communication implicate thrombin in the control of vascular fibrinolysis.
The addition of physiological concentrations of thrombin to confluent monolayers of bovine ECs caused a rapid and extensive loss of intracellular PA activity (Fig. 1) . The half-maximal response was observed at Media alonet 84 84 60 * Monolayers were exposed to thrombin (1 U/ml), and at the indicated times cell extracts (intracellular) and CM (extracellular) were tested for PA activity. The results are compared to those obtained from the appropriate untreated controls.
I Serum-free CM was prepared overnight, removed from cells, and treated with thrombin for the indicated times. The results are expressed as the percentage of untreated, incubated controls.
=0.1 nM thrombin, in agreement with the dissociation constant for the thrombin-EC receptor (8) . The decrease was complete within 30 min (Table II) , and in preliminary kinetic experiments, thrombin (1 U/ml) reduced intracellular PA activity by 65% within 1 min at 37°C (15) . The mechanism by which thrombin caused the decrease in intracellular PA activity is unclear. DFP-inactivated thrombin still binds to ECs (8), but active thrombin is apparently required both to suppress intracellular PA (Table I) , and to stimulate prostacyclin release (9) . The mitogenic activity of thrombin can be accounted for entirely by its action on the cell surface (16) , suggesting that its effect on PA may be initiated by similar surface changes. In addition, it seems likely that intracellular calcium is important, because the presence of calcium ionophore also decreases intracellular PA (15) and stimulates prostacyclin release (9) . Thrombin itself causes a rapid influx of calcium ions into ECs (17) . How changes in the concentration of this important regulatory ion lead to loss of intracellular PA is unclear. Elevated rates of secretion appear to be ruled out since PA is secreted at a much lower rate in the presence of thrombin (Fig. 2) . The possibility that thrombin itself directly inactivated PA was considered. Although the addition of thrombin to CM appeared to inactivate PA, it did so at a rate considerably slower than the observed loss (Table II) . The possibilities that thrombin activates a cellular inhibitor of fibrinolysis (3, 4) , initiates degradation of PA, or inhibits synthesis of PA are being investigated.
In conclusion, these results indicate that the generation of thrombin in the vasculature may promote hemostasis not only by aggregating platelets and promoting coagulation, but also by suppressing the thrombolytic potential of the endothelium.
